Skip to main content

Table 5 30-day Outcomes

From: Long-term outcome after mitral valve replacement using biological versus mechanical valves

  Biological MVR
N = 265
Mechanical MVR
N = 59
Odds Ratio
95% CI
Adjusted Odds Ratioa
95% CI
Death, % 23/265 (8.7) 6/59 (10.2) 0.84 (0.33–2.16) 0.50 (0.17–1.52)
 Cardiac death, % 15/265 (5.7) 4/59 (6.8) 0.88 (0.28–2.75) 0.66 (0.18–2.42)
 Non-cardiac death, % 8/265 (3.0) 2/59 (3.4) 0.89 (0.18–4.29) 0.37 (0.06–2.32)
Stroke, % 11/265 (4.2) 2/59 (3.4) 1.23 (0.27–5.72) 0.47 (0.08–2.66)
Acute renal failure, % 27/265 (10.2) 7/59 (11.9) 0.85 (0.35–2.05) 0.45 (0.16–1.24)
Myocardial infarction, % 0/265 (0) 2/59 (3.4) n.a. n.a.
Pacemaker implantation, % 20/264 (7.6) 6/59 (10.2) 0.45 (0.16–1.29) 0.72 (0.28–1.89)
Re-thoracotomy, % 33/265 (12.5) 13/59 (22.0) 0.50 (0.25–1.03) 0.45 (0.20–1.00)
  1. Legend: Values are patients applicable/patients with available information with percentage in brackets
  2. n.a. not applicable
  3. aOdds ratios were calculated by logistic regression and adjusted for age, logistic EuroScore-I, CAD and MV insuff. ≥ grade II (preOP)